News
U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...
50% on copper, 200% on pharmaceuticals: How Trump’s tariffs may hit India where it hurts | Explained
For India – the world’s largest supplier of generic medicines to the United States and an emerging player in copper-based ...
The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...
The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...
India is the largest supplier of generic drugs, accounting for about 20% of the global supply. It manufactures about 60,000 ...
1d
Inquirer.net on MSNDOH to public: Save more by buying generic medicinesThe Department of Health (DOH) on Wednesday encouraged the public to buy more generic medicines as it announced that the ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...
Rising prices stressing you out? Me too. Follow these simple dos and don’ts, and you might become a bulk-buying evangelist ...
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
Complaints made against Swiss bank over losses on foreign exchange derivatives in wake of US tariff announcements.
It turns out that your trash can be a surprisingly accurate mirror of your income level. From the brands you buy to the ...
While Vietnam’s pharmaceutical manufacturers may face limited immediate exposure to the recent shifts in US drug pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results